Received: 6 March 2019
Revised: 3 April 2019
Accepted: 5 April 2019
First Online: 19 April 2019
Compliance with ethical standards
: Dr. Andersen, Dr. Heje, and Dr. Buch reports no disclosure. Dr. Vissing reports having received research and travel support, and/or speaker honoraria from Sanofi/Genzyme, Ultragenyx Pharmaceuticals, Santhera Pharmaceuticals and aTyr Pharma, and served as consultant on advisory boards for Sanofi/Genzyme, aTyr pharma, Ultragenyx Pharmaceuticals, Santhera Pharmaceuticals, Sarepta Therapeutics, NOVO Nordisk, Alexion Pharmaceuticals and Stealth Biotherapeutics within the last 3 years.